Patel, R. R., Sengupta, S., Kim, H. R., Klein-Szanto, A. J., Pyle, J. R., Zhu, F., . . . Jordan, V. C. (2010). Experimental Treatment of Estrogen Receptor (ER) Positive Breast Cancer with Tamoxifen and Brivanib Alaninate, a VEGFR-2/FGFR-1 Kinase Inhibitor: A potential clinical application of angiogenesis inhibitors.
استشهاد بنمط شيكاغوPatel, Roshani R., et al. Experimental Treatment of Estrogen Receptor (ER) Positive Breast Cancer With Tamoxifen and Brivanib Alaninate, a VEGFR-2/FGFR-1 Kinase Inhibitor: A Potential Clinical Application of Angiogenesis Inhibitors. 2010.
MLA استشهادPatel, Roshani R., et al. Experimental Treatment of Estrogen Receptor (ER) Positive Breast Cancer With Tamoxifen and Brivanib Alaninate, a VEGFR-2/FGFR-1 Kinase Inhibitor: A Potential Clinical Application of Angiogenesis Inhibitors. 2010.